Accordingly, cell RNA-seq profiles from human EGFR mutant lung adenocarcinomas tumor samples demonstrated that FA metabolism and ROS pathway signatures were gradually increased during treatment from naïve to resistant relapsed tumors [67]. The gene discussed is EGFR; the disease is neoplasm.